{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:12:28Z","timestamp":1789744348161,"version":"4.0.1"},"posted":{"date-parts":[[2026,9,15]]},"group-title":"Cancer Biology","reference-count":65,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  RAS mutations are found in nearly 50% of follicular thyroid cancers (FTCs), frequently accompanied by secondary mutations in the PI3K\/AKT pathway as tumors advance to more poorly differentiated states. To examine the role that oncogenic\n                  <jats:italic>Hras<\/jats:italic>\n                  plays in thyroid tumor initiation and progression, we developed murine models with thyroid-specific expression of\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                  <\/jats:italic>\n                  combined with heterozygous or homozygous loss of\n                  <jats:italic>Pten.<\/jats:italic>\n                  Loss of\n                  <jats:italic>Pten<\/jats:italic>\n                  cooperated with\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                  <\/jats:italic>\n                  in a dose-dependent manner to induce the development of follicular thyroid carcinoma and poorly-differentiated thyroid carcinoma. Histopathology of\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  tumors closely resembled those from the established\n                  <jats:italic>\n                    Kras\n                    <jats:sup>G12D<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  model, but tumor onset was significantly delayed in\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  mice. At three weeks of age, downregulation of MAPK pathway inhibitors was observed in\n                  <jats:italic>\n                    Kras\n                    <jats:sup>G12D<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  thyroids, accompanied by increased MAPK pathway activation compared to\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  mice. Furthermore, amplification of oncogenic\n                  <jats:italic>Ras<\/jats:italic>\n                  was found in\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                  <\/jats:italic>\n                  tumors and cell lines, while allelic balance was maintained in\n                  <jats:italic>\n                    Kras\n                    <jats:sup>G12D<\/jats:sup>\n                  <\/jats:italic>\n                  models. These studies demonstrate clear phenotypic differences between mutant\n                  <jats:italic>Hras<\/jats:italic>\n                  and\n                  <jats:italic>Kras<\/jats:italic>\n                  in the thyroid and suggest that delayed MAPK activation may mediate the increased tumor latency observed in the\n                  <jats:italic>\n                    Hras\n                    <jats:sup>G12V<\/jats:sup>\n                    \/Pten\n                    <jats:sup>Hom<\/jats:sup>\n                  <\/jats:italic>\n                  model.\n                <\/jats:p>","DOI":"10.64898\/2026.09.09.750413","type":"posted-content","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:30:25Z","timestamp":1789518625000},"source":"Crossref","is-referenced-by-count":0,"title":["<i>\n                    Hras\n                    <sup>G12V<\/sup>\n                  <\/i>\n                  induces follicular thyroid cancer with attenuated MAPK activation and increased latency compared to\n                  <i>\n                    Kras\n                    <sup>G12D<\/sup>\n                  <\/i>"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0002-7583","authenticated-orcid":false,"given":"Nicholas E.","family":"Bambach","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3308-1620","authenticated-orcid":false,"given":"Katherine","family":"Labella","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee Ann","family":"Jolly","sequence":"additional","affiliation":[{"name":"Department of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Isabel","family":"Cruz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Massol","sequence":"additional","affiliation":[{"name":"Department of Pathology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2537-3228","authenticated-orcid":false,"given":"Antonio","family":"Di Cristofano","sequence":"additional","affiliation":[{"name":"Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1677-5228","authenticated-orcid":false,"given":"Aime T.","family":"Franco","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Endocrinology and Diabetes, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"Department of Pediatrics, University of Pennsylvania, Philadephia, PA"},{"name":"Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026091808000608000_2026.09.09.750413v1.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.2719"},{"issue":"4","key":"2026091808000608000_2026.09.09.750413v1.2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaoto.2014.1","article-title":"Current thyroid cancer trends in the United States","volume":"140","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2026091808000608000_2026.09.09.750413v1.3","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0155"},{"key":"2026091808000608000_2026.09.09.750413v1.4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-1-20"},{"issue":"1","key":"2026091808000608000_2026.09.09.750413v1.5","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eprac.2025.08.009","article-title":"Anaplastic Thyroid Carcinoma: A Contemporary Review of Challenges and Advances","volume":"32","year":"2026","journal-title":"Endocr Pract"},{"issue":"3","key":"2026091808000608000_2026.09.09.750413v1.6","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/thy.2018.0509","article-title":"Poorly Differentiated Carcinoma of the Thyroid Gland: Current Status and Future Prospects","volume":"29","year":"2019","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"2026091808000608000_2026.09.09.750413v1.7","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.142"},{"key":"2026091808000608000_2026.09.09.750413v1.8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85271"},{"key":"2026091808000608000_2026.09.09.750413v1.9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-2953"},{"key":"2026091808000608000_2026.09.09.750413v1.10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0373"},{"key":"2026091808000608000_2026.09.09.750413v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2010.167"},{"key":"2026091808000608000_2026.09.09.750413v1.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-4259"},{"key":"2026091808000608000_2026.09.09.750413v1.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-2281"},{"key":"2026091808000608000_2026.09.09.750413v1.14","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0727"},{"key":"2026091808000608000_2026.09.09.750413v1.15","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1125"},{"key":"2026091808000608000_2026.09.09.750413v1.16","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0273"},{"key":"2026091808000608000_2026.09.09.750413v1.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2009.10.016"},{"issue":"11-12","key":"2026091808000608000_2026.09.09.750413v1.18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1159\/000515731","article-title":"The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance","volume":"93","year":"2020","journal-title":"Horm Res Paediatr"},{"key":"2026091808000608000_2026.09.09.750413v1.19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2351"},{"key":"2026091808000608000_2026.09.09.750413v1.20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0024"},{"key":"2026091808000608000_2026.09.09.750413v1.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1233"},{"issue":"4","key":"2026091808000608000_2026.09.09.750413v1.22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/clinem\/dgab851","article-title":"Characterization of Subtypes of BRAF-Mutant Papillary Thyroid Cancer Defined by Their Thyroid Differentiation Score","volume":"107","year":"2022","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"2026091808000608000_2026.09.09.750413v1.23","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-17-0532"},{"key":"2026091808000608000_2026.09.09.750413v1.24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0900343106"},{"key":"2026091808000608000_2026.09.09.750413v1.25","doi-asserted-by":"publisher","DOI":"10.1002\/gene.20043"},{"key":"2026091808000608000_2026.09.09.750413v1.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0000059"},{"issue":"12","key":"2026091808000608000_2026.09.09.750413v1.27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/thy.1999.9.1265","article-title":"Improved radioimmunoassay for measurement of mouse thyrotropin in serum: strain differences in thyrotropin concentration and thyrotroph sensitivity to thyroid hormone","volume":"9","year":"1999","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"issue":"9","key":"2026091808000608000_2026.09.09.750413v1.28","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1089\/thy.2011.0030","article-title":"Establishment and characterization of cell lines from a novel mouse model of poorly differentiated thyroid carcinoma: powerful tools for basic and preclinical research","volume":"21","year":"2011","journal-title":"Thyroid : official journal of the American Thyroid Association"},{"key":"2026091808000608000_2026.09.09.750413v1.29","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0095"},{"key":"2026091808000608000_2026.09.09.750413v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.09.050"},{"issue":"5","key":"2026091808000608000_2026.09.09.750413v1.31","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers","volume":"104","year":"2019","journal-title":"The Journal of clinical endocrinology and metabolism"},{"key":"2026091808000608000_2026.09.09.750413v1.32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1015557108"},{"key":"2026091808000608000_2026.09.09.750413v1.33","doi-asserted-by":"publisher","DOI":"10.1210\/en.137.1.375"},{"key":"2026091808000608000_2026.09.09.750413v1.34","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0047"},{"key":"2026091808000608000_2026.09.09.750413v1.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065095"},{"key":"2026091808000608000_2026.09.09.750413v1.36","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-1385"},{"key":"2026091808000608000_2026.09.09.750413v1.37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00347.2009"},{"issue":"2","key":"2026091808000608000_2026.09.09.750413v1.38","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1742-4658.2012.08716.x","article-title":"Dual-specificity MAP kinase phosphatases (MKPs)","volume":"280","year":"2013","journal-title":"FEBS Journal"},{"key":"2026091808000608000_2026.09.09.750413v1.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-008-9123-1"},{"key":"2026091808000608000_2026.09.09.750413v1.40","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20141957"},{"key":"2026091808000608000_2026.09.09.750413v1.41","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.2541"},{"key":"2026091808000608000_2026.09.09.750413v1.42","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.489"},{"key":"2026091808000608000_2026.09.09.750413v1.43","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0330"},{"key":"2026091808000608000_2026.09.09.750413v1.44","doi-asserted-by":"publisher","DOI":"10.1038\/304596a0"},{"key":"2026091808000608000_2026.09.09.750413v1.45","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2012.27.9.1014"},{"issue":"4","key":"2026091808000608000_2026.09.09.750413v1.46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12022-013-9263-x","article-title":"Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm","volume":"24","year":"2013","journal-title":"Endocrine pathology"},{"key":"2026091808000608000_2026.09.09.750413v1.47","doi-asserted-by":"crossref","unstructured":"Rinaldi S , Plummer M , Biessy C , Tsilidis KK , Ostergaard JN , Overvad K , Tjonneland A , Halkjaer J , Boutron-Ruault MC , Clavel-Chapelon F , Dossus L , Kaaks R , Lukanova A , Boeing H , Trichopoulou A , Lagiou P , Trichopoulos D , Palli D , Agnoli C , Tumino R , Vineis P , Panico S , Bueno-de-Mesquita HB , Peeters PH , Weiderpass E , Lund E , Quiros JR , Agudo A , Molina E , Larranaga N , Navarro C , Ardanaz E , Manjer J , Almquist M , Sandstrom M , Hennings J , Khaw KT , Schmidt J , Travis RC , Byrnes G , Scalbert A , Romieu I , Gunter M , Riboli E , Franceschi S . Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. Journal of the National Cancer Institute. 2014;106(6):dju097.","DOI":"10.1093\/jnci\/dju097"},{"issue":"1","key":"2026091808000608000_2026.09.09.750413v1.48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.kint.2022.03.020","article-title":"The impact of genetic background on mouse models of kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"2026091808000608000_2026.09.09.750413v1.49","doi-asserted-by":"crossref","first-page":"112073","DOI":"10.1016\/j.celrep.2023.112073","article-title":"Crosstalk between ILC2s and Th2 cells varies among mouse models","volume":"42","year":"2023","journal-title":"Cell Rep"},{"key":"2026091808000608000_2026.09.09.750413v1.50","doi-asserted-by":"publisher","DOI":"10.1186\/s13395-024-00344-4"},{"key":"2026091808000608000_2026.09.09.750413v1.51","doi-asserted-by":"crossref","unstructured":"Olguin V , Duran A , Las Heras M , Rubilar JC , Cubillos FA , Olguin P , Klein AD . Genetic Background Matters: Population-Based Studies in Model Organisms for Translational Research. Int J Mol Sci. 2022;23(14).","DOI":"10.3390\/ijms23147570"},{"key":"2026091808000608000_2026.09.09.750413v1.52","doi-asserted-by":"publisher","DOI":"10.1038\/ng.115"},{"key":"2026091808000608000_2026.09.09.750413v1.53","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00234-07"},{"key":"2026091808000608000_2026.09.09.750413v1.54","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0778"},{"key":"2026091808000608000_2026.09.09.750413v1.55","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0096"},{"key":"2026091808000608000_2026.09.09.750413v1.56","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210239"},{"key":"2026091808000608000_2026.09.09.750413v1.57","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.24.17164"},{"key":"2026091808000608000_2026.09.09.750413v1.58","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21367"},{"key":"2026091808000608000_2026.09.09.750413v1.59","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgl063"},{"key":"2026091808000608000_2026.09.09.750413v1.60","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.37.24052"},{"issue":"7","key":"2026091808000608000_2026.09.09.750413v1.61","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.molonc.2015.04.001","article-title":"KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells","volume":"9","year":"2015","journal-title":"Mol Oncol"},{"issue":"8","key":"2026091808000608000_2026.09.09.750413v1.62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4103\/1947-2714.163641","article-title":"Amplification of Cellular Oncogenes in Solid Tumors","volume":"7","year":"2015","journal-title":"N Am J Med Sci"},{"key":"2026091808000608000_2026.09.09.750413v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/nature25459"},{"key":"2026091808000608000_2026.09.09.750413v1.64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44342-4"},{"issue":"5","key":"2026091808000608000_2026.09.09.750413v1.65","doi-asserted-by":"crossref","first-page":"569","DOI":"10.5858\/2010-0664-RAIR.1","article-title":"Molecular Diagnostics of Thyroid Tumors","volume":"135","year":"2011","journal-title":"Archives of Pathology & Laboratory Medicine"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.09.750413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:00:35Z","timestamp":1789743635000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.09.750413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":65,"URL":"https:\/\/doi.org\/10.64898\/2026.09.09.750413","relation":{},"subject":[],"published":{"date-parts":[[2026,9,15]]},"subtype":"preprint"}}